| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/11/2011 | CN101607013B Chinese medicament coaptation capsule and preparation method |
| 05/11/2011 | CN101525391B Method for extracting amylase from liquorice and application thereof |
| 05/11/2011 | CN101513483B Rhizoma cibotii and eucommia bark soup used for curing protrusion of lumbar intervertebral disc |
| 05/11/2011 | CN101301406B Externally applied agent for treating hyperosteogeny, disc herniation, cervical vertebra inflammation and rheumathritis |
| 05/11/2011 | CN101301379B Chinese medicinal composition and preparation and use thereof |
| 05/11/2011 | CN101274060B Loins-strengthening and kidney-invigorating paste |
| 05/11/2011 | CN101254302B Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 05/11/2011 | CN101234141B Total alkaloid of stephania delavayi and preparation and application thereof |
| 05/11/2011 | CN101167778B Semen vaccariae extraction for inhibiting angiogenesis and preparation and application thereof |
| 05/11/2011 | CN101054352B New strontium salts of sulphonic acids, a process for their preparation and pharmaceutical compositions containing them |
| 05/11/2011 | CN101036706B Wine for promoting blood circulation, removing blood stasis and eliminating rheumatism |
| 05/10/2011 | USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them |
| 05/10/2011 | US7939655 Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 05/10/2011 | US7939639 Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology |
| 05/10/2011 | US7938641 Extrusion die |
| 05/10/2011 | CA2519063C Immunomodulating heterocyclic compounds |
| 05/10/2011 | CA2483105C Autoimmune conditions and nadph oxidase defects |
| 05/10/2011 | CA2478335C Amino-methyl substituted tetracycline compounds |
| 05/10/2011 | CA2475498C Piperidine derivative and pharmaceutical composition comprising the same as active ingredient |
| 05/10/2011 | CA2467471C Derivatives of andrimid and moiramide b having antibacterial properties |
| 05/10/2011 | CA2463102C Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 05/10/2011 | CA2436935C Serine protease inhibitors |
| 05/10/2011 | CA2417806C New immunoeffector compounds |
| 05/05/2011 | WO2011053653A2 Prevotella histicola preparations and the treatment of autoimmune conditions |
| 05/05/2011 | WO2011052950A2 Pharmaceutical composition comprising indole compound |
| 05/05/2011 | WO2011052668A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/05/2011 | WO2011051673A1 Aminothiazole derivatives useful as klk1 inhibitors |
| 05/05/2011 | WO2011050599A1 Humanized recombinant uricase and mutants thereof |
| 05/05/2011 | WO2011050394A1 Methods and compositions for the treatment of osteoarticular disease |
| 05/05/2011 | WO2011005574A9 Compositions and methods for regulating chondrocyte proliferation in bone disorders |
| 05/05/2011 | WO2010031248A8 Thiazolium salt compound and the use of treating the protein aging disease |
| 05/05/2011 | US20110107443 Novel protein transduction domains derived from secretory leukocyte protease inhibitor |
| 05/05/2011 | US20110105959 Novel Methods for Bone Treatment by Modulating an Arachidonic Acid Metabolic or Signaling Pathway |
| 05/05/2011 | US20110105748 Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 05/05/2011 | US20110105613 Moisture resistant container systems for rapidly bioavailable dosage forms |
| 05/05/2011 | US20110105611 Use of maslinic acid for the treatment of pathologies and their symptoms through the inhibition of cox-2 |
| 05/05/2011 | US20110105607 Lipophilic diesters of chelating agent for inhibition of enzyme activity |
| 05/05/2011 | US20110105563 Il-8 receptor antagonists |
| 05/05/2011 | US20110105562 Alkynyl derivatives useful as dpp-1 inhibitors |
| 05/05/2011 | US20110105548 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
| 05/05/2011 | US20110105538 Drug response markers |
| 05/05/2011 | US20110105537 5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors |
| 05/05/2011 | US20110105528 1-(7-(hexahydropyrrolo [3, 4-c] pyrrol-2 (1h)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3) |
| 05/05/2011 | US20110105527 Pyrazines as delta opioid receptor modulators |
| 05/05/2011 | US20110105505 Thiazolyl piperidine derivatives |
| 05/05/2011 | US20110105499 Pyrazolo-Pyrazinone Compounds and Methods of Use Thereof |
| 05/05/2011 | US20110105498 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105440 HEXAHYDROCYCLOPENTYL[f]INDAZOLE SULFONAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 05/05/2011 | US20110105432 Aminocarboxylic acid derivative and medicinal use thereof |
| 05/05/2011 | US20110105430 Pyrrolo [2,3-c] pyridine derivatives as p38 kinease inhibiting agents |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105401 Peptide composition and a method of promoting cartilage formation |
| 05/05/2011 | US20110105396 Tgf-beta3 mutants |
| 05/05/2011 | US20110104308 Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide |
| 05/05/2011 | US20110104296 Endorphin Therapy Compositions and Methods |
| 05/05/2011 | US20110104284 Hyaluronic acid derivative based three-dimensional matrix |
| 05/05/2011 | US20110104283 Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis |
| 05/05/2011 | US20110104278 Bone tissue substitute, a solidifiable bone precursor and method of making same |
| 05/05/2011 | US20110104265 Compositions and methods of targeted nanoformulations in the management of osteoporosis |
| 05/05/2011 | US20110104258 Technique for drug and gene delivery to the cell cytosol |
| 05/05/2011 | US20110104253 Agent for intra-articular injection |
| 05/05/2011 | US20110104238 Wettable fillers for improved release of hydrophilic materials from chewing gum compositions |
| 05/05/2011 | US20110104237 Bone strengthening food supplement |
| 05/05/2011 | US20110104233 Flowable composition that sets to a substantially non-flowable state |
| 05/05/2011 | US20110104232 Sustained Release Systems of Ascorbic Acid Phosphate |
| 05/05/2011 | US20110104231 Bioceramic and biopolymer composite |
| 05/05/2011 | US20110104230 Compositions of novel bone patch in bone and vascular regeneration |
| 05/05/2011 | US20110104229 Bone Xenograft |
| 05/05/2011 | US20110104217 Bioactive Peptides and Method of Using Same |
| 05/05/2011 | US20110104185 Antibody fragment-polymer conjugates and uses of same |
| 05/05/2011 | US20110104176 Antibody specifically binding to c-met and use thereof |
| 05/05/2011 | US20110104172 Inhibitors of gm-csf and il-17 for therapy |
| 05/05/2011 | US20110104170 Novel composition and methods for the treatment of immune related diseases |
| 05/05/2011 | US20110104169 Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications |
| 05/05/2011 | US20110104152 Chimeric fibroblast growth factors with altered receptor specificity |
| 05/05/2011 | US20110104145 Method for the treatment or prophylaxis of chronic inflammatory diseases |
| 05/05/2011 | US20110104139 ANGIOSTATIC COMPOSITIONS COMPRISING TRUNCATED TYROSYL-tRNA SYNTHETASE POLYPEPTIDES AND METHODS OF USING SAME |
| 05/05/2011 | US20110104127 mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | DE102009051066A1 Composition, useful for preparing a drug for treating e.g. limbs-, tendon-, muscle pain, comprises a carrier medium, menthol, horse chestnut seed extract, white willow bark extract, Arnica tincture, rosemary oil and St. John's wort oil |
| 05/05/2011 | CA2779111A1 Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis |
| 05/05/2011 | CA2778759A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/04/2011 | EP2316944A2 Binding agents: chimeric ligand/receptor proteins |
| 05/04/2011 | EP2316855A1 Antihuman Alpha-9 integrin antibody and use of the same |
| 05/04/2011 | EP2316852A1 Stabilized single domain antibodies |
| 05/04/2011 | EP2316851A1 Antibody inhibitors of GDF-8 and uses thereof |
| 05/04/2011 | EP2316845A1 Specific binding agents of human angiopoietin-2 |
| 05/04/2011 | EP2316487A1 Recombinant IL-9 antibodies & uses thereof |
| 05/04/2011 | EP2316473A1 Use of calcitonin in osteoarthritis |
| 05/04/2011 | EP2316465A1 Use of extract of leeches' saliva as anti-bacterial agent for the manufacture of different compositons |
| 05/04/2011 | EP2316462A1 Pharmaceutical kits comprising mesenchymal stem cells |
| 05/04/2011 | EP2316455A1 Pharmaceutical compositions for treating cancer |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2316445A1 HUMAN beta3 ADRENERGIC RECEPTOR LIGAND, AND FOOD OR PHARMACEUTICAL PRODUCT CONTAINING THE SAME |
| 05/04/2011 | EP2315780A1 Compositions and methods of use for therapeutic antibodies |
| 05/04/2011 | EP2315765A2 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 05/04/2011 | EP2315756A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 05/04/2011 | EP2315754A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 05/04/2011 | EP2315604A2 Dicarba-analgues of octreotide |